Monitoring oral anticoagulation in primary care
- 8 June 1996
- Vol. 312 (7044) , 1431-1432
- https://doi.org/10.1136/bmj.312.7044.1431
Abstract
The purpose of oral anticoagulant treatment is to decrease thrombotic episodes, particularly stroke, by interfering with the haemostatic pathways.3 The intensity of anticoagulant effect required for any particular indication remains controversial.4 There have been problems in standardising test results between different centres at local and international levels. Data showing wide international variation in mean warfarin doses—Hong Kong under 2 mg, North America over 8 mg, and British figures between these extremes5—led to international collaboration to improve testing and …Keywords
This publication has 9 references indexed in Scilit:
- Aiming for Safe AnticoagulationNew England Journal of Medicine, 1995
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995
- Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.1995
- Thromboplastin related differences in the determination of international normalised ratio: a cause for concern? Steering Committee of the UK National External Quality Assessment Scheme in Blood Coagulation.1994
- Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation.BMJ, 1993
- Impact of introducing near patient testing for standard investigations in general practice.BMJ, 1993
- Anticoagulant-related bleeding: Clinical epidemiology, prediction, and preventionThe American Journal of Medicine, 1993
- Survey of prothrombin time in National External Quality Assessment Scheme exercises (1980-87).Journal of Clinical Pathology, 1988
- Dosage and control of oral anticoagulants: an international collaborative surveyBritish Journal of Haematology, 1982